Aline Engbers
PhD candidate
- Name
- Dr. A.G.J. Engbers
- Telephone
- +31 71 527 2727
- a.g.j.engbers@lacdr.leidenuniv.nl
- ORCID iD
- 0000-0002-7230-0091
PhD candidate
- Science
- Leiden Academic Centre for Drug Research
- LACDR/Pharmacology
- Engbers A.G.J. (19 December 2023), Dosing considerations for preterm neonates: from pharmacometrics to clinical practice (Dissertatie. Leiden Academic Centre for Drug Research (LACDR), Faculty of Science, Leiden University). Supervisor(s) and Co-supervisor(s): Knibbe C.A.J. & Reiss I.K.M., Simons S.H.P. & Völler S.
- Engbers A.G.J., Flint R.B., Völler S., Reiss I., Liem K.D., Alffenaar J.W.C., Tibboel D., Simons S., Knibbe C.A.J. & Bruggemann R.J. (2022), Optimisation of fluconazole therapy for the treatment of invasive candidiasis in preterm infants, Archives of disease in childhood 107(4): 400-406.
- Engbers A.G.J., Völler S., Flint R.B., Goulooze S.C., Klerk J. de, Krekels E.H.J., Dijk M. van, Willemsen S.P., Reiss I.K.M., Knibbe C.A.J. & Simons S.H.P. (2022), The effect of ibuprofen exposure and patient characteristics on the closure of the patent Ductus Arteriosus in preterm infants, Clinical Pharmacology & Therapeutics 112(2): 307-315.
- Smit C., Engbers A.G.J., Samiee-Zafarghandy S., Donge T. van, Simons S.H.P., Flint R.B., Pfister M., Knibbe C.A.J. & Anker J.N. van den (2022), Oral ibuprofen is more effective than intravenous ibuprofen for closure of a patent ductus arteriosus: can pharmacokinetic modeling help us to understand why?, Neonatology : 1-9.
- Flint R.B., Simons S.H.P., Andriessen P., Liem K.D., Degraeuwe P.L.J., Reiss I.K.M., Ter Heine R., Engbers A.G.J., Koch B.C.P., Groot R. de, Burger D.M., Knibbe C.A..J. & Völler S. (2021), The bioavailability and maturing clearance of doxapram in preterm infants, Pediatric Research 89: 1268-1277.
- Engbers A.G.J., Voller S., Poets C.F., Knibbe C.A.J., Reiss I.K.M., Koch B.C.P., Flint R.B. & Simons S.H.P. (2021), The pharmacokinetics of caffeine in preterm newborns: no influence of doxapram but important maturation with age, Neonatology 118(1): 106-113.
- Engbers A.G.J., Flint R.B., Voller S., Klerk J.C.A., Reiss I.K.M., Andriessen P., Liem K.D., Degraeuwe P.L.J., Croubels S., Millecam J., Allegaert K., Simons S.H.P. & Knibbe C.A.J. (2020), Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosus, British Journal of Clinical Pharmacology 86(10): 2028-2039.